OIMU
DGX icon

Osmosis Investment Management UK’s Quest Diagnostics DGX Stock Holding History

Osmosis Investment Management UK’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500K Sell
2,358
-2,151
-48% -$422K 0.02% 355
2026
Q1 		$884K Buy
+4,509
New +$876K 0.02% 336

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Osmosis Investment Management UK's DGX Position: Q2 2026 in Review

Osmosis Investment Management UK reduced its Quest Diagnostics (DGX) stake by 48% in Q2 2026, selling an estimated $422K and leaving 2,358 shares worth $500K. The position accounts for 0.02% of the portfolio, ranked #355.

Osmosis Investment Management UK first reported a position in DGX in Q1 2026 and has held it in 2 quarters since. The position peaked at $884K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Osmosis Investment Management UK held 2,358 shares of Quest Diagnostics worth $500K as of Q2 2026.
  • Osmosis Investment Management UK sold 2,151 Quest Diagnostics shares in Q2 2026, an estimated $422K.
  • Quest Diagnostics made up 0.02% of Osmosis Investment Management UK's portfolio in Q2 2026, its #355 holding.
  • Osmosis Investment Management UK first reported a position in Quest Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • Osmosis Investment Management UK's Quest Diagnostics position peaked at $884K in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.